As of Mar 27
| +0.21 / +4.79%|
The 1 analysts offering 12-month price forecasts for Alimera Sciences Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +117.86% increase from the last price of 4.59.
The current consensus among 2 polled investment analysts is to Buy stock in Alimera Sciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.